[go: up one dir, main page]

NO932129L - Fremgangsmaate for fremstilling og anvendelse av nye tienotiazinderivater - Google Patents

Fremgangsmaate for fremstilling og anvendelse av nye tienotiazinderivater

Info

Publication number
NO932129L
NO932129L NO932129A NO932129A NO932129L NO 932129 L NO932129 L NO 932129L NO 932129 A NO932129 A NO 932129A NO 932129 A NO932129 A NO 932129A NO 932129 L NO932129 L NO 932129L
Authority
NO
Norway
Prior art keywords
chain
lower alkyl
single bond
heteroaryl
procedure
Prior art date
Application number
NO932129A
Other languages
English (en)
Other versions
NO932129D0 (no
Inventor
Dieter Binder
Josef Weinberger
Original Assignee
Chem Pharm Forsch Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chem Pharm Forsch Gmbh filed Critical Chem Pharm Forsch Gmbh
Publication of NO932129D0 publication Critical patent/NO932129D0/no
Publication of NO932129L publication Critical patent/NO932129L/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D513/00Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/02Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
    • C07D513/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Pain & Pain Management (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Rheumatology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)

Abstract

Tienotlazinderivater med generell formel (I) der X betyr en enkeltbinding, en rettkjedet eller forgrenet karbonkjede med 1-12 C-atomer i kjeden, der denne kjeden kan inneholde en eller flere dobbelt- eller trippelbindinger og/eller en eller flere heteroatomer, Y betyr en enkeltbinding, og R betyr hydrogen, en monocyklisk eller polycyklisk, eventuelt delvis hydrert aryl-, heteroaryl-, aryloksy-, heteroaryloksy-, arylaza-, heteroaryl- aza-, aryltio- eller heteroaryltiorest, som eventuelt kan være substituert med laverealkyl, en eller flere ganger halogenert laverealkyl, per- fluorert laverealkyl, alkoksy eller halogen, med den forutsetning at R ikke betyr hydrogen når X og Y betyr en enkeltbinding. Det beskrives også fremgangsmåte for fremstilling av disse forbindelsene.
NO932129A 1992-07-03 1993-06-10 Fremgangsmaate for fremstilling og anvendelse av nye tienotiazinderivater NO932129L (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
AT0136092A AT399880B (de) 1992-07-03 1992-07-03 Neue thienothiazinderivate, verfahren zu ihrer herstellung und ihre verwendung

Publications (2)

Publication Number Publication Date
NO932129D0 NO932129D0 (no) 1993-06-10
NO932129L true NO932129L (no) 1994-01-04

Family

ID=3512206

Family Applications (1)

Application Number Title Priority Date Filing Date
NO932129A NO932129L (no) 1992-07-03 1993-06-10 Fremgangsmaate for fremstilling og anvendelse av nye tienotiazinderivater

Country Status (23)

Country Link
US (1) US5527796A (no)
EP (1) EP0576906A1 (no)
JP (1) JPH06157543A (no)
KR (1) KR940005638A (no)
CN (1) CN1083066A (no)
AT (1) AT399880B (no)
AU (1) AU662229B2 (no)
CA (1) CA2097167A1 (no)
CZ (1) CZ129693A3 (no)
EE (1) EE9400148A (no)
FI (1) FI932863A7 (no)
HR (1) HRP931016A2 (no)
HU (1) HUT68733A (no)
IL (1) IL105774A (no)
LT (1) LT3159B (no)
LV (1) LV10618B (no)
MD (1) MD940297A (no)
MY (1) MY109432A (no)
NO (1) NO932129L (no)
NZ (1) NZ247690A (no)
SI (1) SI9300356A (no)
SK (1) SK63893A3 (no)
ZA (1) ZA933899B (no)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AT400845B (de) * 1993-12-06 1996-03-25 Chem Pharm Forsch Gmbh Neue thienothiazinderivate, ein verfahren zu ihrer herstellung und ihre verwendung
EP0658559A1 (de) * 1993-12-14 1995-06-21 Chemisch Pharmazeutische Forschungsgesellschaft m.b.H. Thienothiazinderivate, Verfahren zu ihrer Herstellung und ihre Verwendung als 5-dipoxygenase und Cyclooxygenaseinhibitoren
DE4400867A1 (de) * 1994-01-14 1995-07-20 Nycomed Arzneimittel Gmbh Neue Thienothiazinderivate, ein Verfahren zu ihrer Herstellung und ihre Verwendung
US5703073A (en) * 1995-04-19 1997-12-30 Nitromed, Inc. Compositions and methods to prevent toxicity induced by nonsteroidal antiinflammatory drugs
US7045519B2 (en) 1998-06-19 2006-05-16 Chiron Corporation Inhibitors of glycogen synthase kinase 3
ATE274510T1 (de) 1998-06-19 2004-09-15 Chiron Corp Glycogen synthase kinase 3 inhibitoren
JP2002528495A (ja) 1998-10-30 2002-09-03 ニトロメド インコーポレーテッド ニトロソ化およびニトロシル化された非ステロイド抗炎症性化合物、組成物および使用方法
CN1171892C (zh) 2001-06-25 2004-10-20 李晶 具有抗炎镇痛活性的噻吩并噻嗪化合物及其制备方法和用途
CN111646987B (zh) * 2020-06-05 2022-06-24 湖南师范大学 一种5-氨基噻唑类非甾体抗炎化合物及其制备方法和用途

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1066711A (en) * 1974-08-26 1979-11-20 Hoffmann-La Roche Limited Thiophene derivatives
MC1135A1 (fr) * 1976-02-23 1977-11-18 Hoffmann La Roche Derives de thiazine
LU78009A1 (de) * 1977-08-22 1979-05-23 Hoffmann La Roche Verfahren zur herstellung von thiazinderivaten
AU518216B2 (en) * 1977-09-06 1981-09-17 Hafslund Nycomed Pharma Aktiengesellschaft Thienothiazine derivatives
EP0103142B1 (de) * 1982-09-09 1987-04-22 F. HOFFMANN-LA ROCHE & CO. Aktiengesellschaft Thieno(2,3-e)-1,2-thiazin-Derivate
IL87951A (en) * 1987-10-29 1992-03-29 Chem Pharm Forsch Gmbh Carbonic acid esters of 6-chloro-4-(1-hydroxyethoxy)-2-methyl-n-(2-pyridyl)-2h-thieno(2,3-e)-1,2-thiazine-3-carboxamide 1,1-dioxide,their preparation and pharmaceutical compositions containing them

Also Published As

Publication number Publication date
HU9301920D0 (en) 1993-09-28
EE9400148A (et) 1995-12-15
LV10618A (lv) 1995-04-20
HUT68733A (en) 1995-07-28
FI932863A0 (fi) 1993-06-21
IL105774A (en) 1997-01-10
NO932129D0 (no) 1993-06-10
LTIP760A (en) 1994-05-15
HRP931016A2 (en) 1997-04-30
AU4172693A (en) 1994-01-06
LT3159B (en) 1995-01-31
CA2097167A1 (en) 1994-01-04
CZ129693A3 (en) 1994-01-19
SK63893A3 (en) 1994-02-02
FI932863L (fi) 1994-01-04
JPH06157543A (ja) 1994-06-03
US5527796A (en) 1996-06-18
AU662229B2 (en) 1995-08-24
MD940297A (ro) 1996-02-29
CN1083066A (zh) 1994-03-02
ATA136092A (de) 1994-12-15
IL105774A0 (en) 1993-09-22
EP0576906A1 (de) 1994-01-05
LV10618B (en) 1996-06-20
KR940005638A (ko) 1994-03-22
MY109432A (en) 1997-01-31
FI932863A7 (fi) 1994-01-04
AT399880B (de) 1995-08-25
SI9300356A (en) 1994-03-31
ZA933899B (en) 1994-06-14
NZ247690A (en) 1994-12-22

Similar Documents

Publication Publication Date Title
NO944700L (no) Nye tienotiazinderivater, fremgangsmåte for fremstilling derav samt farmasöytiske preparater inneholdende forbindelsene
MY107756A (en) Piperazine derivatives.
TWI224595B (en) New benzazepine derivatives, drugs containing these and use of the same for producing drugs
IE781878L (en) Imidazole derivatives
DK0625977T3 (da) Piperazinderivater som 5-1A-antagonister
DE69722027D1 (de) Kristalle von benzimidazolderivate und verfahren zu ihrer herstellung
NO932129L (no) Fremgangsmaate for fremstilling og anvendelse av nye tienotiazinderivater
NZ511067A (en) Serine protease inhibiting isoquinoline derivatives and their use for treating or preventing thrombin-mediated or thrombin-associated diseases
PH31304A (en) Piperazine derivatives as 5-ht antagonists.
EP0144986A3 (en) Indole-3-carboxamide derivatives
DK129282A (da) Fremgangsmaade til fremstilling af indolylethylderivater
SE8802790D0 (sv) Tripeptider med immunostimulerande och metastasforhindrande verkan
WO1994020459A3 (en) Pyrrolo-pyridine derivatives as dopamine receptor ligands
IE40570B1 (en) Benzylamine derivatives and process for preparing them
CA2048010A1 (en) Proline derivatives
ES8401067A1 (es) Procedimiento analogo para preparar un derivado de tropil benzoato.
ES2073258T3 (es) Nuevos derivados de la urea, su preparacion y su aplicacion en terapeutica.
FR2672213B1 (fr) Utilisation de derives 4-(3-trifluoromethylphenyl)-1,2,3,6-tetrahydropyridiniques comme capteurs de radicaux libres.
WO2000027832A3 (en) Thiazole derivatives as ppar gamma ligands
PL307333A1 (en) Improved antiandrogens
NO944680L (no) Nye tienotiazinerivater, en fremgangsmåte til fremstilling derav samt deres anvendelse
NO950974L (no) Nye N,N,N',N'-tetrasubstituert-1,2-etandiaminderivatforbindelser
DK149270C (da) Analogifremgangsmaade til fremstilling af beta-carbolin-3-carboxylsyrederivater
ES8604853A1 (es) Un metodo para la preparacion de un derivado de acetileno.
GB1399470A (en) Derivatives of pyrazolopyridine ketones